Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models.

Petcherski, Anton; Sharma, Madhav; Satta, Sandro; Daskou, Maria; Vasilopoulos, Hariclea; Hugo, Cristelle; Ritou, Eleni; Dillon, Barbara Jane; Fung, Eileen; Garcia, Gustavo; Scafoglio, Claudio; Purkayastha, Arunima; Gomperts, Brigitte N; Fishbein, Gregory A; Arumugaswami, Vaithilingaraja; Liesa, Marc; Shirihai, Orian S; Kelesidis, Theodoros

Petcherski, Anton; Sharma, Madhav; Satta, Sandro; Daskou, Maria; Vasilopoulos, Hariclea; Hugo, Cristelle; Ritou, Eleni; Dillon, Barbara Jane; Fung, Eileen; Garcia, Gustavo; Scafoglio, Claudio; Purkayastha, Arunima; Gomperts, Brigitte N; Fishbein, Gregory A; Arumugaswami, Vaithilingaraja; Liesa, Marc; Shirihai, Orian S; Kelesidis, Theodoros.

bioRxiv ; 2022 Jun 23.

Article en En | MEDLINE | ID: mdl-35233569

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887067
https://dx.doi.org/10.1101/2022.02.22.481100

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: BioRxiv Año: 2022 Tipo del documento: Article